A Brazilian company developing innovative products and services that meet the expectations of healthcare professionals is looking for partners for the Formatting of CTD Dossiers.

Reply

Comments :

sandeep.dynamic@outlook.com

please send complete details

12:38,  26 Nov 2018
Reply

saviopharma.in@gmail.com

We will do, kindly share your details with us.

13:59,  26 Nov 2018
Reply

bd@delnovahealth.com

We Can help you on same. We are COntract Development company and support till eCTD filing.

15:59,  26 Nov 2018
Reply

ashu.elitien@gmail.com

Ashok G

15:45,  01 Dec 2018
Reply

ashu.elitien@gmail.com

I have experience in preparation of finished dossiers for regulated markets, Kindly find my email id and share your requirement.

15:47,  01 Dec 2018
Reply

hostrinlifesciences@gmail.com

Hii,
We are expertize in the Dossiers compilation and submission in the fortmat of CTD,ACTD,eCTD etc for various regions. All are successfully registration's.

We do support you for the Dossiers preparation with all modules or parts including BE/Clinical studies data.

Please don't hesitate to contact me.

Best Regards,
Andrew P
CEO & MD,
Hostrin Life Sciences,
www.hostringlobal.com
andrew@hostringlobal.com.

16:35,  06 Dec 2018
Reply

sharath@regpakbiopharma.com

Regpak biopharma is an Amsterdam based regulatory and pharmcovigelence services providing company. We help you in formatting of CTD Dossiers. Please reach me on email. For more info visit www.regpakbiopharma.com

12:01,  08 Dec 2018
Reply

PharmaCompass – Grow Your Pharma Business Digitally. What is Telmisartan? Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension. Generally, angiotensin II receptor blockers (ARBs) such as telmisartan bind to the angiotensin II type 1 (AT1) receptors with high affinity, causing inhibition of the action of angiotensin II on vascular smooth muscle, ultimately leading to a reduction in arterial blood pressure. Recent studies suggest that telmisartan may also have PPAR-gamma agonistic properties that could potentially confer beneficial metabolic effects.

ABOUT
THE PAGE

COLLAPSE